| Pharmaceutical active ingredients: |
| Griseofulvin Ultramicrocrystalline |
| Available forms, composition and doses of Fulvicin P / G: |
| Tablets; Oral; Griseofulvin Ultramicrocrystalline 125 mgTablets; Oral; Griseofulvin Ultramicrocrystalline 165 mgTablets; Oral; Griseofulvin Ultramicrocrystalline 250 mgTablets; Oral; Griseofulvin Ultramicrocrystalline 330 mg |
| Fulvicin P / G medical category: |
| Human:Antifungals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AA08 - GriseofulvinD01BA01 - Griseofulvin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Griseofulvin | Griseofulvin Microcrystalline | Actavis |
| Griseofulvin | Griseofulvin Microcrystalline | Stiefel Laboratories |
| Griseofulvina | Griseofulvin Microcrystalline | Chile Laboratorios |
| Grisoral | Griseofulvin Microcrystalline | Bal Pharma |
| Rexavin | Griseofulvin Microcrystalline | Ifars Pharmaceutical Laboratories |
| Grisactin Ultra | Griseofulvin Ultramicrocrystalline | Wyeth |
| Gris-PEG | Griseofulvin Ultramicrocrystalline | Pedinol Pharmacal; Novartis; Wander |
| Polygris | Griseofulvin Ultramicrocrystalline | Essex |
| Ultragris | Griseofulvin Ultramicrocrystalline | Pliva |
| Griseofulvin | Griseofulvin; Salicylic Acid | Farkos NPF |